WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022

May 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-05-23

Reporting Person: Birkett Bernard (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-23	Stock Options (Right to buy)	$303.34	A	1344.00	Acquired	2032-05-23	Stock Options (Right to Buy) (1344.00)	Direct

Footnotes

F1: This award vests in four equal annual installments beginning on May 23, 2023.